https://www.selleckchem.com/pr....oducts/dabrafenib-gs
nonemergent neurological conditions significantly decreased during the pandemic. In the era of value-based payment models, it is imperative for neurosurgeons to eliminate inefficiencies and provide high-quality care. Discharge disposition is a relevant consideration with clinical and economic ramifications in brain tumor patients. We developed a predictive model and online calculator for postoperative non-home discharge disposition in brain tumor patients that can be incorporated into preoperative workflows. We reviewed al
Like
Comment
Share
